Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Interaction of von Willebrand factor with human platelets in the plasma milieu.
J Schullek, … , J Jordan, R R Montgomery
J Schullek, … , J Jordan, R R Montgomery
Published February 1, 1984
Citation Information: J Clin Invest. 1984;73(2):421-428. https://doi.org/10.1172/JCI111228.
View: Text | PDF
Research Article

Interaction of von Willebrand factor with human platelets in the plasma milieu.

  • Text
  • PDF
Abstract

The binding of von Willebrand factor (vWf) to stimulated platelets in the plasma milieu was performed using a radiolabeled monoclonal antibody to vWf. Plasma proteins specifically inhibited the thrombin- and ADP/epinephrine-induced vWf binding to activated platelets but did not inhibit the ristocetin-induced vWf binding. When normal plasma was heat defibrinated, monoclonal-labeled vWf was bound to platelets following thrombin or ADP/epinephrine stimulation. Furthermore, monoclonal-labeled vWf from afibrinogenemic plasma bound normally to platelets. The binding of vWf to stimulated platelets in either heat-defibrinated normal plasma or afibrinogenemic plasma was specifically inhibited by the addition of normal plasma fibrinogen in a concentration-dependent manner. At levels of fibrinogen less than 1 mg/ml, however, vWf binding could be demonstrated. The inhibition by fibrinogen of vWf binding to platelets was competitive and overcome by increased concentrations of vWf. These studies show that thrombin-induced and ADP/epinephrine-induced vWf binding to platelets does not occur in the plasma milieu, although at reduced levels of fibrinogen, vWf binding to stimulated platelets can be demonstrated.

Authors

J Schullek, J Jordan, R R Montgomery

×

Total citations by year

Year: 2016 2012 2011 2004 2003 2002 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1949 Total
Citations: 1 2 2 1 1 2 2 1 1 2 1 1 1 1 5 5 3 2 3 10 10 11 1 69
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (69)

Title and authors Publication Year
Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A
SW Pipe, RR Montgomery, KP Pratt, PJ Lenting, D Lillicrap
Blood 2016
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Characterization of Zebrafish von Willebrand Factor Reveals Conservation of Domain Structure, Multimerization, and Intracellular Storage
A Ghosh, A Vo, BK Twiss, CA Kretz, MA Jozwiak, RR Montgomery, JA Shavit
Advances in Hematology 2012
Von Willebrand Disease
PM Mannucci, M Franchini
Von Willebrand Disease 2011
Von Willebrand Disease: Basic and Clinical Aspects
J Batlle, A Pérez-Rodríguez, MF López-Fernández
Von Willebrand Disease: Basic and Clinical Aspects 2011
In vitro study of a triple-secured von Willebrand factor concentrate
C Mazurier, M Poulle, B Samor, L Hilbert, S Chtourou
Vox Sanguinis 2004
Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen
M Jirousková, I Chereshnev, H Väänänen, JL Degen, BS Coller
Blood 2003
Identification of the Regulatory Elements of the Human von Willebrand Factor for Binding to Platelet GPIb: IMPORTANCE OF STRUCTURAL INTEGRITY OF THE REGIONS FLANKED BY THE CYS 1272 –CYS 1458 DISULFIDE BOND
T Nakayama, T Matsushita, Z Dong, JE Sadler, S Jorieux, C Mazurier, D Meyer, T Kojima, H Saito
The Journal of biological chemistry 2002
Two Clusters of Charged Residues Located in the Electropositive Face of the Von Willebrand Factor A1 Domain Are Essential for Heparin Binding
G Rastegar-Lari, BO Villoutreix, AS Ribba, P Legendre, D Meyer, D Baruch
Biochemistry 2002
Localization of von Willebrand Factor-binding Sites for Platelet Glycoprotein Ib and Botrocetin by Charged-to-Alanine Scanning Mutagenesis
T Matsushita, D Meyer, JE Sadler
The Journal of biological chemistry 2000
Effect of recombinant von Willebrand factor reproducing type 2B or type 2M mutations on shear-induced platelet aggregation
N Ajzenberg, AS Ribba, G Rastegar-Lari, D Meyer, D Baruch
Blood 2000
A proposed psychosomatic etiologic model for rheumatoid arthritis
KA Schiel
Medical Hypotheses 1999
Type 2M von Willebrand Disease: F606I and I662F Mutations in the Glycoprotein Ib Binding Domain Selectively Impair Ristocetin- but not Botrocetin-Mediated Binding of von Willebrand Factor to Platelets
CA Hillery, DJ Mancuso, JE Sadler, JW Ponder, MA Jozwiak, PA Christopherson, JC Gill, JP Scott, RR Montgomery
Blood 1998
Atherosclerosis
EM MD, ST MD, EA MD, AW MD, ED MD
The Annals of Thoracic Surgery 1997
Advances in Molecular and Cell Biology
KJ Clemetson
Advances in Molecular and Cell Biology 1997
Disorders of platelet function
I Fuse
Critical Reviews in Oncology/Hematology 1996
Immunopharmacology of Platelets
MH Kroll, AI Schafer
Immunopharmacology of Platelets 1995
Purification and characterization of human platelet von Willebrand factor
SB Williams, LP McKeown, H Krutzsch, K Hansmann, HR Gralnick
British Journal of Haematology 1994
Mr 6,400 aurin tricarboxylic acid directly activates platelets
Z Guo, MJ Weinstein, MD Phillips, MH Kroll
Thrombosis Research 1993
New RGD analogue inhibits human platelet adhesion and aggregation and eliminates platelet deposition on canine vascular grafts
BG Rubin, DJ McGraw, GA Sicard, SA Santoro
Journal of Vascular Surgery 1992
Electrophoretic and functional characteristics of the von Willebrand factor in human fetal plasma
C Mazurier, F Daffos, F Forestier
British Journal of Haematology 1992
Elution of fibrinogen and other plasma proteins from unmodified and from lecithin-coated polystyrene—divinylbenzene beads
BC Cook, GS Retzinger
Journal of Colloid and Interface Science 1992
Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease
AS Ribba, J Voorberg, D Meyer, H Pannekoek, G Pietu
The Journal of biological chemistry 1992
Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy
JW Weisel, C Nagaswami, G Vilaire, JS Bennett
The Journal of biological chemistry 1992
The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress
Y Ikeda, M Handa, K Kawano, T Kamata, M Murata, Y Araki, H Anbo, Y Kawai, K Watanabe, I Itagaki
Journal of Clinical Investigation 1991
Integrin Structure and Function in Hemostasis and Thrombosis
JS Bennett
Annals of the New York Academy of Sciences 1991
In vitro Evaluation of a Very-High-Purity, Solvent/Detergent-Treated, Von Willebrand Factor Concentrate
C Mazurier, S Jorieux, C Romeuf, B Samor, M Goudemand
Vox Sanguinis 1991
Definition of the affinity of binding between human von willebrand factor and coagulation factor VIII
PR Ganz, JS Atkins, DS Palmer, AK Dudani, S Hashemi, F Luison
Biochemical and Biophysical Research Communications 1991
Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets
JP Scott, RR Montgomery, GS Retzinger
The Journal of biological chemistry 1991
Enhanced botrocetin-induced type iib von willebrand factor binding to platelet glycoprotein ib initiates hyperagglutination of normal platelets
K Nishio, Y Fujimura, K Niinomi, Y Takahashi, A Yoshioka, H Fukui, Y Usami, K Titani, ZM Ruggeri, TS Zimmerman
American Journal of Hematology 1990
Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins
A Golden, JS Brugge, SJ Shattil
The Journal of Cell Biology 1990
Platelets and Thrombolytic Therapy
JS Flier, LH Underhill, BS Coller
New England Journal of Medicine 1990
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate
HJ Weiss, J Hawiger, ZM Ruggeri, VT Turitto, P Thiagarajan, T Hoffmann
Journal of Clinical Investigation 1989
Spontaneous platelet aggregation in type IIB tampa von willebrand disease is inhibited by the 52/48-kDa fragment of normal von willebrand factor, which contains the GPIb binding domain
HI Saba, Y Fujimura, SR Saba, AC Bruce, GA Morelli, ZM Ruggeri, TS Zimmerman
American Journal of Hematology 1989
Type IIB von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy
MF López-Fernández, C López-Berges, JA Martin-Bernal, R Sánchez, LG Villarón, J Díez-Jarilla, J Batlle
American Journal of Hematology 1988
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson
1988
Platelet-Vessel Wall Interactions
RM Pittilo, SJ Machin
1988
Thrombogenic and Nonthromboge0nic Biological Surfaces
JF Mustard, HM Groves, RL Kinlough-Rathbone, MA Packham
Annals of the New York Academy of Sciences 1987
Endothelial Cell Processing of von Willebrand Proteins
Y Kawai, RR Montgomery
Annals of the New York Academy of Sciences 1987
Role of von Willebrand Factor in Platelet Vessel-Wall Interactions
D Meyer, E Fressinaud, KS Sakariassen, HR Baumgartner, JP Girma
Annals of the New York Academy of Sciences 1987
Assessment of Multimeric Structure and Ristocetin-Induced Binding to Platelets of Von Willebrand Factor Present in Cryoprecipitate and Different Factor VIII Concentrates
MF López-Fernández, C López-Berges, M Corral, JR García-Talavera, AL Borrasca, J Batlle
Vox Sanguinis 1987
Blood Elements at Surfaces: Platelets
BS Coller
Annals of the New York Academy of Sciences 1987
Factor VIII / von Willebrand Factor
TS Zimmerman
Annals of the New York Academy of Sciences 1987
Formation and regulation of platelet and fibrin hemostatic plug
J Hawiger
Human Pathology 1987
von Willebrand disease
TS Zimmerman, ZM Ruggeri
Human Pathology 1987
Inhibition of von willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser
S Williams, H Gralnick
Thrombosis Research 1987
Platelet-type von willebrand disease platelet aggregating factor: A novel functional assay of von willebrand factor
H Takahashi, W Tatewaki, M Hanano, A Shibata
Thrombosis Research 1987
Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor
P Bockenstedt, JM Greenberg, RI Handin
Journal of Clinical Investigation 1986
von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia
LD Marco, A Girolami, TS Zimmerman, ZM Ruggeri
Journal of Clinical Investigation 1986
von Willebrand protein facilitates platelet incorporation in polymerizing fibrin
J Loscalzo, A Inbal, RI Handin
Journal of Clinical Investigation 1986
The physiology and pathophysiology of the factor VIII complex
RJ Hamer, WP Houdijk, JJ Sixma, TW Barrowcliffe
Critical Reviews in Oncology/Hematology 1986
The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium
KS Sakariassen, PF Nievelstein, BS Coller, JJ Sixma
British Journal of Haematology 1986
Synthesis by cultured human umbilical vein endothelial cells of two proteins structurally and immunologically related to platelet membrane glycoproteins IIb and IIIa
PJ Newman, Y Kawai, RR Montgomery, TJ Kunicki
The Journal of Cell Biology 1986
Thrombin enhanced adhesion of platelets to von willebrand factor substrates
SA Santoro, JF Cowan
Thrombosis Research 1986
Characterization of a fragment of bovine von Willebrand factor that binds to platelets
MA Mascelli, TS Edgington, EP Kirby
Biochemistry 1986
Platelet Membrane Glycoprotein IIb/IIIa: Member of a Family of Arg-Gly-Asp—Specific Adhesion Receptors
R Pytela, MD Pierschbacher, MH Ginsberg, EF Plow, E Ruoslahti
Science 1986
von Willebrand factor binds specifically to sulfated glycolipids
DD Roberts, SB Williams, HR Gralnick, V Ginsburg
The Journal of biological chemistry 1986
Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation
HR Grainick, SB Williams, BS Coller
Journal of Clinical Investigation 1985
Endothelial cell synthesis of von Willebrand antigen II, von Willebrand factor, and von Willebrand factor/von Willebrand antigen II complex
DR McCarroll, EG Levin, RR Montgomery
Journal of Clinical Investigation 1985
Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor
HR Grainick, SB Williams, LP McKeown, ME Rick, P Maisonneuve, C Jenneau, Y Sultan
Journal of Clinical Investigation 1985
Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody
VT Lombardo, E Hodson, JR Roberts, TJ Kunicki, TS Zimmerman, ZM Ruggeri
Journal of Clinical Investigation 1985
Platelet - von Willebrand factor interactions in Type IIB von Willebrand's disease
L Holmberg, AC Kristoffersson, S Lamme, IM Nilsson, A Awidi, NO Solum
Scandinavian Journal of Haematology 1985
Molecular cloning of cDNA for human von willebrand factor: Authentication by a new method
DC Lynch, TS Zimmerman, CJ Collins, M Brown, MJ Morin, EH Ling, DM Livingston
Cell 1985
On the association of glycoprotein Ib and actin-binding protein in human platelets
JR Okita, D Pidard, PJ Newman, RR Montgomery, TJ Kunicki
The Journal of Cell Biology 1985
Extracellular matrices and cell adhesion
E Ruoslahti, EG Hayman, MD Pierschbacher
Arteriosclerosis (Dallas, Tex.) 1985
Immunology of Rheumatic Diseases
S Gupta, N Talal
1985
Mechanisms of Stimulus—Response Coupling in Platelets
J Westwick, MF Scully, DE MacIntyre, VV Kakkar
1985
Platelet Membrane Glycoproteins
JN George, AT Nurden, DR Phillips
1985
Hematology
JJ Shea, JJ Shea
The Laryngoscope 1949

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts